✦ LIBER ✦

Clinical pattern and associations of oxaliplatin acute neurotoxicity : A prospective study in 170 patients with colorectal cancer

✍ Scribed by Andreas A. Argyriou; Guido Cavaletti; Chiara Briani; Roser Velasco; Jordi Bruna; Marta Campagnolo; Paola Alberti; Francesca Bergamo; Diego Cortinovis; Marina Cazzaniga; Cristina Santos; Konstantinos Papadimitriou; Haralabos P. Kalofonos

Book ID: 112067279
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 145 KB
Volume: 119
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27732

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peripheral neurotoxicity of oxaliplatin

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

✍ Argyriou, A. A.; Velasco, R.; Briani, C.; Cavaletti, G.; Bruna, J.; Alberti, P.; 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 133 KB

Phase I drug-interaction study of effect

Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients

✍ Han, Catherine H; Khwaounjoo, Prashannata; Kilfoyle, Dean H; Hill, Andrew; McKea 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 424 KB

Dynamics of antioxidants in patients wit

Dynamics of antioxidants in patients with acute pancreatitis and in patients operated for colorectal cancer: A clinical study

✍ František Musil; Zdeněk Zadák; Dagmar Solichová; Radomír Hyšpler; Milan Kaška; L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Neuroprotective effect of neurotropin on

Neuroprotective effect of neurotropin on chronic oxaliplatin-induced neurotoxicity in stage II and stage III colorectal cancer patients: results from a prospective, randomised, single-centre, pilot clinical trial

✍ R. X. Zhang, Z. H. Lu, D. S. Wan, X. J. Wu… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 132 KB

A randomised phase II study of oxaliplat

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

✍ A. Zori Comba; C. Blajman; E. Richardet; S. Bella; M. Vilanova; F. Cóppola; M. V 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 134 KB

A prospective validation pharmacogenomic

A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen

✍ Cecchin, E; D'Andrea, M; Lonardi, S; Zanusso, C; Pella, N; Errante, D; De Mattia 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 385 KB